Nivolumab plus standard-of-care does not meet primary endpoint for mCRC Presented ByDr Heinz-Josef Lenz, USC Norris Comprehensive Cancer Center, CA, USA TrialPhase 3, CheckMate 9X8 ConferenceASCO GI 2022 21 March, 2022 10:21
ASCO GI 2022 Highlights Podcast Presented ByDr Rachel Giles, Medicom ConferenceASCO GI 2022 8 February, 2022 12:37